| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 4.0 | 10.5 | 4.2 |
| Total income | 4.0 | 10.6 | 4.2 |
| Profit before exceptional items & tax | 0.1 | 0.5 | 0.1 |
| Profit before tax | 0.1 | 0.5 | 0.1 |
| Net profit | 0.1 | 0.4 | 0.1 |
| Operating margin | 2.5% | 4.7% | 2.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | -75.00% |
| Revenue, year on year | -4.80% |
BSE results filing, NSE: INTEGFD. Figures extracted from the filing.
Integrated Proteins Ltd: key numbers
- Share price
- ₹14.11
- Market cap
- ₹264.1 Cr
- Revenue (annual)
- ₹9.94 Cr
- Net profit (annual)
- ₹0.22 Cr
- P/E (TTM)
- 419.9×Sector 40.6×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Integrated Proteins Ltd
All →Integrated Proteins Board Meeting Date
Integrated Proteins will hold a board meeting on November 5, 2026 to approve unaudited results for the quarter and half year ended September 30, 2026. The trading window reopens on November 7, 2026.
Integrated Proteins Management Change
Integrated Proteins appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, effective 29 October 2026. The appointment was approved at a board meeting as a Key Managerial Personnel change.
Integrated Proteins Other Announcement
Integrated Proteins Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Integrated Proteins Management Change
Integrated Proteins Limited appointed Sandeep Mahadik as Non-Executive Independent Director and Ankita Shah as Secretarial Auditor, both effective September 30, 2026.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd held its Annual General Meeting on September 30, 2026. Shareholders considered resolutions regarding financial statements and company appointments.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd has announced its 33rd Annual General Meeting scheduled for September 30, 2026, via video conferencing to transact business including financial statement adoption.